Related Experiment Videos
Insights
A psychotic preschooler developed seizures during imipramine treatment, a known risk for seizure-prone individuals. Alternative treatments are recommended over tricyclic antidepressants for this patient group.
Area of Science:
- Child and Adolescent Psychiatry
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Tricyclic antidepressants (TCAs) like imipramine are used for pediatric mental health conditions.
- Seizure disorders are a potential concern in certain patient populations.
- Preschool-aged children present unique challenges in psychopharmacological treatment.
Observation:
- A case study involving a preschool-aged child diagnosed with psychosis.
- The child was undergoing treatment with imipramine.
- The child subsequently developed a seizure disorder.
Findings:
- The patient's history and physical examination indicated a predisposition to seizures.
- Imipramine treatment was associated with the onset of seizure activity in this susceptible child.
- This case highlights a potential adverse drug reaction in a vulnerable pediatric population.
Implications:
- Clinicians should exercise caution when prescribing TCAs to seizure-prone children.
- Alternative psychopharmacological or non-pharmacological treatments may be preferable for these individuals.
- Further research into the safety of TCAs in pediatric populations with seizure risk factors is warranted.
Abstract:
The authors report the case of a psychotic preschool child who manifested a seizure disorder while on imipramine treatment. They note that according to his history and physical exam, the child fell within a group which seems predisposed to this side effect. Although tricyclic antidepressant compounds can be used judiciously with seizure-prone individuals, the authors recommend that alternative modalities be given first consideration.